Study A0221049, which was a 12-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter trial was designed to compare the efficacy and safety of a flexible dose regimen of fesoterodine to
As per the joint venture, Samsung will contribute $255m of the $300 million for an 85% stake and Biogen Idec will contribute $45m for a 15% stake in
The randomised double-blind placebo-controlled Phase 1a/1b clinical trial will evaluate the safety, tolerability, pharmacokinetic profile and antiviral activity of ACH-2928. The clinical study includes three segments: assessment of
The new solutions are McKesson Ambulatory Pharmacy Solutions, ExpressRx Track and AcuDose-Rx. McKesson Ambulatory Pharmacy Solutions is a portfolio of purchasing, inventory, retail, reimbursement and consulting services that
The Cellulite Reduction Formula by Futura, codenamed CRF100, is an alkaloid containing topically applied cream that comprises DermaSys delivery system. CRF100 has demonstrated an eight-fold improvement in delivery
The investment is intended for the manufacturing of the antidepressant Seroxat and the HIV treatment Retrovir, thediplomat.ro reported. The company is said to export drugs to more than
The facility which will begin commercial production of the drugs in January 2012, is expected to manufacture at least 100 million tablets every year, theeastafrican.co.ke reported. The generic
According to the terms of the deal, Pfizer provided Excaliard’s shareholders, including Isis Pharmaceuticals, Alta Partners, ProQuest Investments and RiverVest Venture Partners, an upfront payment and will make
The partnership intends to support product development regulatory compliance goals. Lancaster Laboratories provides GMP and GLP services, including protein characterization, cell bank testing, viral clearance studies and method
The integrated analysis of two parallel Phase 3 studies (VIEW 1 and VIEW 2) in patients with the neovascular form of age-related macular degeneration (wet AMD) was reported.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.